AYTU BIOPHARMA, INC 10-Q filing
Filed 2025-11-13 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001437749-25-034825
- Form type
- 10-Q
- CIK
- 0001385818
- Primary document
- https://www.sec.gov/Archives/edgar/data/1385818/000143774925034825/aytu20250930_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AYTU BIOPHARMA, INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $13.9M | - | - |
| Cost Of Revenue | $4.7M | - | - |
| Gross Profit | $9.2M | - | - |
| Operating Income | $-1.5M | - | - |
| Net Income | $2.0M | - | - |
| Eps Basic | 0.21 | - | - |
| Eps Diluted | -0.08 | - | - |
| Cash And Equivalents | $32.6M | - | - |
| Total Assets | $125.0M | - | - |
| Shareholders Equity | $23.2M | - | - |
| Operating Cash Flow | $-618,000 | - | - |
| Capital Expenditures | $0 | - | - |